Key Facts Surrounding This News Item
- APLS had returned 0.00% year-to-date leading up to today’s news, versus a +17.57% return from the benchmark S&P 500 during the same period.
More Info About Apellis Pharmaceuticals, Inc. (APLS)
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The company was founded in 2009 and is based in Crestwood, Kentucky. View our full APLS ticker page with ratings, news, and more.